NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/09/2025
Voltar para busca
Dado oficial do USPTO
PURAPHARM ONCO-Z
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Snapshot rápido
PURAPHARM ONCO-Z
ST13
US500000098045875Classe
5
Pedido
98045875
Registro
7924439
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
23
Atualização mais recente
02/09/2025
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
16/06/2023
Data de registro
02/09/2025
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/09/2025
Última transação
02/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
77
Localização do titular
Tai Po, NT, HK
Examinador
BHANOT, KAPIL KUMAR
Unidade examinadora
L80
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
PuraPharm International (H.K.) Limited
Representantes
Haverly MacArthur ADAMS AND REESE LLP
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations and medical and veterinary preparations for strengthening the immune system and restoring normal bodily functions; pharmaceutical preparations and medical and veterinary preparations for the treatmentmitigation and prevention of diseases and disordersdigestive diseases and disorders and obesity; pharmaceutical preparations and medical and veterinary preparations for central nervous system diseases and disordersbrain diseasescognitive disordersmovement disordersocular motility; pharmaceutical preparations and medical and veterinary preparations for respiratory diseases and disorders; pharmaceutical preparations and medical and veterinary preparations for excretory diseases and disorders; pharmaceutical preparations and medical and veterinary preparations for cardiovascular diseases and disorders; pharmaceutical preparations and medical and veterinary preparations for reproductive diseases and disorders; pharmaceutical preparations and medical and veterinary preparations for endocrinal diseases and disorders; pharmaceutical preparations and medical and veterinary preparations for immunological diseases and disordersautoimmune diseasesimmunologic deficiency syndromehepatitis; pharmaceutical preparations and medical and veterinary preparations for dermatological diseases and disorders; pharmaceutical preparations and medical and veterinary preparations for bone diseasesback painmuscular dystrophy and inflammatory muscle diseases; pharmaceutical preparations and medical and veterinary preparations for blindness; sanitary preparations for medical purposes and for personal hygieneother than toiletries; dietetic food and substances adapted for medical or and veterinary use; food for babies; dietary supplements for human beings and animals; plasters for medical purposes; material for stopping teethdental wax; disinfectants; preparations for destroying vermin; fungicidesherbicides; nutritional supplements; Chinese patent medicinesherbal medicines for the treatment of tumors and for enhancing the immune system; herbal supplementslingzhi; herbal supplementsyunzhi; herbal supplements in the form of granulespillscapsules and tablets containing yunzhi for the treatment of cancer and cancer affections; herbal supplements in the form of granulespillscapsules and tablets containing lingzhi for the treatment of cancer and cancer affections; herbal supplements containing yunzhi (corioulus versicolor) in the form of capsulesgranulespills and tablets for the treatment of tumors and for enhancing the immune system
Publicações
Histórico de despachos e eventos da marca no USPTO.
23 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
02/09/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/07/2025
PUBO
PUBLISHED FOR OPPOSITION
15/07/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/07/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/06/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/06/2025
ALIE
ASSIGNED TO LIE
02/06/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
20/05/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/03/2025
GNSL
LETTER OF SUSPENSION E-MAILED
06/03/2025
CNSL
SUSPENSION LETTER WRITTEN
06/03/2025
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
06/03/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
22/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/03/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
08/03/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/03/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
08/03/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/03/2024
DOCK
ASSIGNED TO EXAMINER
06/03/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/07/2023
NWAP
NEW APPLICATION ENTERED
20/06/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PURAPHARM ONCO-Z ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.